“Antibody Drug Conjugates Market: Global Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth and Forecast, 2023-2028” provides a deep and thorough evaluation of the antibody drug conjugates market by drugs (adcetris, kadcyla); by mechanism of action (LgG1 antibodies, HER2 antibodies); by technology used ADCs (SGEN, IMGN, IMMU, Others); by application (breast cancer, lymphoma); and by geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa).Antibody drug conjugates are biopharmaceutical drugs that are composed of complex molecules of anti-cancer drugs or other cell-killing agents attached to monoclonal antibodies. They are designed to target specific antigens found on target cells, thereby making them highly effective and less prone to causing side effects. They are majorly employed in the healthcare sector for the treatment of a wide variety of medical ailments.
The rising prevalence of cancer across the globe due to the high rates of smoking, alcohol and tobacco consumption has fueled the demand for antibody drug conjugates for their treatment. Furthermore, extensive research and development (R&D) activities related to antibody therapies, advanced drug discoveries and preclinical research are also expected to propel the market growth.
Antibody Drug Conjugates Market Key Segments:
Segmentation by Drugs:
Segmentation by Mechanism of Action:
Segmentation by Application:
Segmentation by Technology used ADCs
Segmentation by Region:
Competitive Landscape:
The price margins for the products along with the various success and risk factors for manufacturers have also been covered in the report. Moreover, in order to determine market attractiveness, the report analyses the antibody drug conjugates industry along the parameters of the porter’s five forces model. This model examines the degree of competition in the antibody drug conjugates industry by analysing the threat posed by new entrants and substitutes, and the bargaining power of suppliers and buyers. Swot analysis of the market has also been presented in the report which highlights the strengths, weaknesses, opportunities and threats pertaining to the antibody drug conjugates industry. Furthermore, the value chain analysis of the antibody drug conjugates industry has also been covered in the report. This comprises of all the activities in the value chain, such as the procurement of various raw materials, manufacturing and sales of the products, and their distribution.
Highlights of The Antibody Drug Conjugates Market
The report is a result of exhaustive primary and secondary research undertaken by analysts having years of experience in the antibody drug conjugates industry. All the qualitative and quantitative aspects of the industry have been covered and the collected data has been analysed and presented in the form of easily comprehensible charts, graphs and tables.
1 Introduction
1.1 Research Objectives
1.2 Stakeholders
1.3 Scope of the Report
1.4 Assumptions and Limitations
2. Research Methodology
2.1. Data Collection
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Data Validation
3. Executive Summary
4. Global Antibody Drug Conjugates Market
4.1 Industry Overview
4.2 Key Industry Developments
4.3 Market Trends
4.3.1 Key Market Indicators
4.3.2 Historical Market Trends
4.3.3 Market Forecast
4.4 Price Analysis
4.4.1 Key Price Indicators
4.4.2 Pricing Structure
4.4.3 Historical Price Trends
4.4.4 Price Forecast
4.5 Market Breakup By Region
4.6 Market Breakup By Drugs
4.7 Market Breakup By Mechanism of Action
4.8 Market Breakup By Application
4.9 Market Breakup By Technology used ADCs
5. Global Antibody Drug Conjugates Market: Value Chain Analysis
5.1 Overview
5.2 Research and Development
5.3 Raw Material Suppliers
5.4 Inbound Logistics
5.5 Production
5.6 Marketing
5.7 Outbound Logistics
5.8 Consumers
6. Global Antibody Drug Conjugates Market: SWOT Analysis
6.1 Overview
6.2 Strengths
6.3 Weaknesses
6.4 Opportunities
6.5 Threats
7. Global Antibody Drug Conjugates Market: Porter’s Five Forces Analysis
7.1 Overview
7.2 Threat of New Entrants
7.3 Threat of Substitutes
7.4 Bargaining Power of Buyers
7.5 Bargaining Power of Suppliers
7.6 Intensity of Rivalry
8. Competitive Landscape
8.1 Market Structure
8.2 Key Players
8.3 Key Success Factors
9. Performance By Region
9.1 North America
9.1.1 Overview
9.1.2 Market Trends
9.1.3 Market Segmentation
9.1.4 Market Forecast
9.2 Europe
9.2.1 Overview
9.2.2 Market Trends
9.2.3 Market Segmentation
9.2.4 Market Forecast
9.3 Asia Pacific
9.3.1 Overview
9.3.2 Market Trends
9.3.3 Market Segmentation
9.3.4 Market Forecast
9.4 Latin America
9.4.1 Overview
9.4.2 Market Trends
9.4.3 Market Segmentation
9.4.4 Market Forecast
9.5 Middle East and Africa
9.5.1 Overview
9.5.2 Market Trends
9.5.3 Market Segmentation
9.5.4 Market Forecast
10 Key Player Profiles
List of Figures
Figure 1: Global: Antibody Drug Conjugates Market, 2017-2022
Figure 2: Global: Antibody Drug Conjugates Market Forecast, 2023-2028
Figure 3: Global: Antibody Drug Conjugates Market: Price Trends, 2017-2022
Figure 4: Global: Antibody Drug Conjugates Market Forecast: Price Trends, 2017-2022
Figure 5: Global: Antibody Drug Conjugates Market: Breakup by Region, 2022
Figure 6: Global: Antibody Drug Conjugates Market: Breakup by Type, 2022
Figure 7: Global: Antibody Drug Conjugates Market: Breakup by End Use, 2022
Figure 8: Global: Antibody Drug Conjugates Industry: Value Chain Analysis
Figure 9: Global: Antibody Drug Conjugates Industry: SWOT Analysis
Figure 10: Global: Antibody Drug Conjugates Industry: Porter’s Five Forces Analysis
Figure 11: Global: Antibody Drug Conjugates Market: Key Players
Figure 12: North America: Antibody Drug Conjugates Market, 2017-2022
Figure 13: North America: Antibody Drug Conjugates Market: Breakup by Segment, 2022
Figure 14: North America: Antibody Drug Conjugates Market Forecast, 2023-2028
Figure 15: Europe: Antibody Drug Conjugates Market, 2017-2022
Figure 16: Europe: Antibody Drug Conjugates Market: Breakup by Segment, 2022
Figure 17: Europe: Antibody Drug Conjugates Market Forecast, 2023-2028
Figure 18: Asia Pacific: Antibody Drug Conjugates Market, 2017-2022
Figure 19: Asia Pacific: Antibody Drug Conjugates Market: Breakup by Segment, 2022
Figure 20: Asia Pacific: Antibody Drug Conjugates Market Forecast, 2023-2028
Figure 21: Latin America: Antibody Drug Conjugates Market, 2017-2022
Figure 22: Latin America: Antibody Drug Conjugates Market: Breakup by Segment, 2022
Figure 23: Latin America: Antibody Drug Conjugates Market Forecast, 2023-2028
Figure 24: Middle East and Africa: Antibody Drug Conjugates Market, 2017-2022
Figure 25: Middle East and Africa: Antibody Drug Conjugates Market: Breakup by Segment, 2022
Figure 26: Middle East and Africa: Antibody Drug Conjugates Market Forecast, 2023-2028
List of Tables
Table 1: Global: Antibody Drug Conjugates Industry: Market Summary
Table 2: Global: Antibody Drug Conjugates Industry: Market Overview, 2022 and 2028
Table 3: Global: Antibody Drug Conjugates Industry: Market Structure
Table 4: Global: Antibody Drug Conjugates Market: Market by Region, 2023-2028
Personalize this research
Triangulate with your own data
Get data as per your format and definition
Gain a deeper dive on a specific application, geography, customer or competitor
Any level of personalization
US: +1-213-316-7435
Uk: +44-702-409-7740
sales@syndicatedanalytics.com
The GCC Weight Management Market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. The market is projected to register a CAGR of X% during 2023-2028, reaching US$ XX Billion by 2028.
Read More The GCC orthopedic braces and supports market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC generic drug market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe GCC telemedicine market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe UAE mhealth market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read MoreThe Saudi Arabia health insurance market was worth US$ XX Billion in 2022, expanding at a CAGR of X% during 2017-2022. Looking forward, the market is projected to grow at a CAGR of around X% during 2023-2028, reaching a value of US$ XX Billion by 2028.
Read More+1-213-316-7435
us.sales@syndicatedanalytics.com
+44-702-409-7740
uk.sales@syndicatedanalytics.com
© Copyright Syndicated Analytics 2023.